Literature DB >> 6317578

Childhood cancer incidence: geographical and temporal variations.

N E Breslow, B Langholz.   

Abstract

Data from the first four volumes of Cancer Incidence in Five Continents (CI-5) and from the first 5 years of the US Surveillance, Epidemiology and End Results (SEER) program were analyzed for evidence of geographical and temporal variations in the incidence of selected childhood tumors. Only lymphoid leukemia and glial neoplasms are common enough for the observed differences between US registries to be distinguished from sampling variation. Internationally, kidney and eye tumors and leukemia show less geographical variation than do lymphomas and brain tumors, but for none of the tumors examined is the incidence constant. Wilms' tumor rates among Japanese, Singapore Chinese and Indians (Bombay) are approximately 60% of the rates in North America and Britain, whereas in Scandinavia the rates are up to 30% higher. This lessens the status of Wilms' tumor as an "index tumor" of childhood. Areas or countries with especially high or low rates of other tumors are identified. Rates for glial neoplasms (SEER data) and Hodgkin's disease (CI-5) are increasing with time in the US, while brain tumors are being diagnosed more frequently worldwide. However, the results for brain tumors may largely reflect changes in pathology diagnosis or reporting practices, and those for Hodgkin's disease may reflect improvements in case ascertainment. Otherwise, there is a remarkable stability in the incidence of selected childhood cancers over time.

Entities:  

Mesh:

Year:  1983        PMID: 6317578     DOI: 10.1002/ijc.2910320609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Wilms' tumor.

Authors:  R P Warrier; O Regueira
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 3.  Paediatric oncology in developing countries.

Authors:  G Prindull
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

4.  Tumor-specific PAX3-FKHR transcription factor, but not PAX3, activates the platelet-derived growth factor alpha receptor.

Authors:  J A Epstein; B Song; M Lakkis; C Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy.

Authors:  E H van Leeuwen; A Postma; J W Oosterhuis; A Meiring; C J Cornelisse; J Koudstaal; W M Molenaar
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

6.  Potential risk factors for brain tumors in children. An analysis of 200 cases.

Authors:  R Giuffrè; G Liccardo; F S Pastore; A Spallone; R Vagnozzi
Journal:  Childs Nerv Syst       Date:  1990-01       Impact factor: 1.475

7.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Maternal and perinatal risk factors for childhood brain tumors (Sweden).

Authors:  M S Linet; G Gridley; S Cnattingius; H S Nicholson; U Martinsson; B Glimelius; H O Adami; M Zack
Journal:  Cancer Causes Control       Date:  1996-07       Impact factor: 2.506

9.  novH: differential expression in developing kidney and Wilm's tumors.

Authors:  G Chevalier; H Yeger; C Martinerie; M Laurent; J Alami; P N Schofield; B Perbal
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 10.  Biological aspects of brain tumors in infancy and childhood.

Authors:  R Giuffrè
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.